Adipose Tissue Carbonylome and Sustained Calorie Restriction
脂肪组织羰基化和持续热量限制
基本信息
- 批准号:9807394
- 负责人:
- 金额:$ 23.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:4 hydroxynonenalAcuteAddressAdipocytesAdipose tissueAffectAgingAldehydesBlood Coagulation DisordersCaloric RestrictionCellsChronic DiseaseCysteineDataDatabasesDevelopmentDyslipidemiasEnergy IntakeFibrinolysisGLUT4 geneGlucose TransporterGoalsHealthHealth BenefitHealth PromotionHistidineHumanHypertensionIndividualInsulinInsulin ResistanceLabelLeadLinkLipid PeroxidationLong-Term EffectsLongevityLysineMalnutritionMediatingModificationMolecularMolecular ConformationMyocardial InfarctionNIH Program AnnouncementsNon obeseNon-Insulin-Dependent Diabetes MellitusObesityOvernutritionOxidative StressPeripheralPeripheral arterial diseasePhysiologicalPost-Translational Protein ProcessingProcessProductionProteinsProteomicsResearchRisk FactorsRoleSeminalSignal PathwaySignal TransductionStressStrokeTestingTransducersTranslatingadductage effectcombatdesignfeedingglucose disposalglucose transporthealthspanhigh rewardhigh riskimprovedinsulin sensitivitymenmultiple reaction monitoringpolypeptidestoichiometrytherapeutic targetwestern diet
项目摘要
Caloric restriction without malnutrition improves lifespan in many species. A hallmark of calorie restriction (CR) is insulin sensitivity. The Comprehensive Assessment of the Long-Term Effects of Reducing Intake of Energy (CALARIE) studies have shown that enhanced insulin sensitivity occurs even in non-obese individuals who undergo CR, and
it is likely a crucial contributor to various positive health benefits found with CR. In general, across several studies, CR improves systemic peripheral insulin sensitivity by reducing oxidative stress, restoring GLUT4 levels in adipocytes, and thus improving whole-body glucose disposal. However, the molecular mechanism on how this occurs in human is poorly understood. A significant attribute associated with insulin resistance is oxidative stress, which can lead to the production of reactive aldehydes such as 4-hydroxynonenal (4-HNE), that can interact with proteins and alter their function. Emerging evidence suggests that when the protein is GLUT4, a covalent modification (carbonylation) near the glucose transport channel represents just such a factor, which translates to insulin resistance. These studies are the basis of our central hypothesis, which states that the mechanism behind improved insulin sensitivity is reduced carbonyl stress and mitigation of GLUT4 carbonylation. We will test this high risk and high reward hypothesis by determining the stoichiometry of GLUT4 carbonylations in adipose tissue of subjects on sustained CR and compare to a group fed ad libitum. We will then correlate this data to several insulin sensitivity and oxidative stress parameters in the CALARIE database. We also aim to assess the effect of sustained CR on adipose tissue global carbonylome. In summary the proposed studies are designed to address the goals of PA-18-824 which “is to encourage analyses that will lead to a more detailed understanding of the effects of caloric restriction (CR) on risk factors for chronic diseases, as well as, the cellular/molecular mechanisms mediating the effects of sustained CR in humans.”
减少能量摄入的长期影响的综合评估 (CALARIE) 研究表明,即使在非营养不良的情况下,热量限制 (CR) 的一个标志是胰岛素敏感性也会增强。 -接受 CR 的肥胖人士,以及
它可能是 CR 带来的各种积极健康益处的关键因素。总的来说,多项研究表明,CR 通过减少氧化应激、恢复脂肪细胞中的 GLUT4 水平来改善全身外周胰岛素敏感性,从而改善全身葡萄糖的处理。与胰岛素抵抗相关的一个重要特征是氧化应激,它可能导致反应性醛类的产生,例如 4-羟基壬烯醛 (4-HNE),但我们对这种情况如何在人类中发生的分子机制知之甚少。新的证据表明,当蛋白质为 GLUT4 时,葡萄糖转运通道附近的共价修饰(羰基化)就代表了这样一个因素,这会转化为胰岛素抵抗。假设,该假设指出改善胰岛素敏感性背后的机制是减少羰基应激和减轻 GLUT4 羰基化,我们将通过确定脂肪组织中 GLUT4 羰基化的化学计量来测试这一高风险和高回报的假设。然后,我们将这些数据与 CALARIE 数据库中的几个胰岛素敏感性和氧化应激参数相关联。摘要 拟议的研究旨在实现 PA-18-824 的目标,即“鼓励进行分析,从而更详细地了解热量限制 (CR) 对慢性病危险因素的影响,以及,这介导人类持续 CR 影响的细胞/分子机制。”
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SALIM MERALI其他文献
SALIM MERALI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SALIM MERALI', 18)}}的其他基金
Activators of Nrf2 Translation in Alzheimer's Disease
阿尔茨海默病中 Nrf2 翻译的激活剂
- 批准号:
9267399 - 财政年份:2016
- 资助金额:
$ 23.78万 - 项目类别:
Detection of Novel Polyamine Analogs with Anti-Prostate Cancer Activity
具有抗前列腺癌活性的新型多胺类似物的检测
- 批准号:
8525356 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
Detection of Novel Polyamine Analogs with Anti-Prostate Cancer Activity
具有抗前列腺癌活性的新型多胺类似物的检测
- 批准号:
8385709 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
The Unfolded Protein Response in Human Airway and Alveolar Epithelial Cells
人类气道和肺泡上皮细胞中未折叠的蛋白质反应
- 批准号:
7837633 - 财政年份:2009
- 资助金额:
$ 23.78万 - 项目类别:
The Unfolded Protein Response in Human Airway and Alveolar Epithelial Cells
人类气道和肺泡上皮细胞中未折叠的蛋白质反应
- 批准号:
7713872 - 财政年份:2009
- 资助金额:
$ 23.78万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7122212 - 财政年份:2004
- 资助金额:
$ 23.78万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
6986225 - 财政年份:2004
- 资助金额:
$ 23.78万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7151923 - 财政年份:2004
- 资助金额:
$ 23.78万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7532766 - 财政年份:2004
- 资助金额:
$ 23.78万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7322500 - 财政年份:2004
- 资助金额:
$ 23.78万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Novel Treatment for Alcohol-associated Liver Disease
酒精相关性肝病的新疗法
- 批准号:
10698605 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Novel Treatment for Alcohol-associated Liver Disease
酒精相关性肝病的新疗法
- 批准号:
10698605 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models
用于治疗前驱阿尔茨海默病模型中空间记忆丧失的新型成像生物标志物
- 批准号:
9925773 - 财政年份:2017
- 资助金额:
$ 23.78万 - 项目类别:
Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models
用于治疗前驱阿尔茨海默病模型中空间记忆丧失的新型成像生物标志物
- 批准号:
10165441 - 财政年份:2017
- 资助金额:
$ 23.78万 - 项目类别: